Cite Filings / CGEM / 0001193125-26-454417
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
10-Q

Quarterly Report

Cullinan Therapeutics, Inc. · Filed 2026-11-10 · Acc 0001193125-26-454417

Documents 1

  • 10-Q Quarterly Report , cgem-20260930.htm

Around this filing

  • 2026-11-10 10-Q Quarterly Report
  • 2026-11-10 8-K Results of operations
  • 2026-11-10 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-11-09 8-K Regulation FD disclosure · Other events
  • 2026-11-06 4 Chief Scientific Officer sold 4,000 shares at $12.36 ($49,440)
  • 2026-11-05 144 Sale of Securities
  • 2026-08-06 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading cgem-20260930.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…